These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38685441)

  • 1. Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets.
    Koch N; Jennotte O; Bourcy Q; Lechanteur A; Deville M; Charlier C; Chiap P; Cardot JM; Evrard B
    Int J Pharm; 2024 May; 657():124173. PubMed ID: 38685441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infant formula as a solid lipid dose form for enhancement of the oral bioavailability of cannabidiol for paediatric patients.
    Huang S; Pham AC; Salim M; Eason T; Ramirez G; Boyd BJ
    Int J Pharm; 2024 Jul; 660():124257. PubMed ID: 38782154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.
    Feng W; Qin C; Chu Y; Berton M; Lee JB; Zgair A; Bettonte S; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
    Eur J Pharm Biopharm; 2021 May; 162():43-49. PubMed ID: 33677067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
    Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
    J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications.
    Adel Ali Youssef A; Hayder Abdelrahman M; Geweda MM; Varner C; Joshi PH; Ghonge M; Dudhipala N; Sulochana SP; Gadepalli RS; Majumdar S
    Int J Pharm; 2024 May; 657():124110. PubMed ID: 38604539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.
    Izgelov D; Davidson E; Barasch D; Regev A; Domb AJ; Hoffman A
    Eur J Pharm Biopharm; 2020 Sep; 154():108-115. PubMed ID: 32634571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb
    Knaub K; Sartorius T; Dharsono T; Wacker R; Wilhelm M; Schön C
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation Development and Evaluation of Cannabidiol Hot-Melt Extruded Solid Self-Emulsifying Drug Delivery System for Oral Applications.
    Sanil K; Almotairy A; Uttreja P; Ashour EA
    AAPS PharmSciTech; 2024 Jun; 25(5):136. PubMed ID: 38862810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol aqueous solubility enhancement: Comparison of three amorphous formulations strategies using different type of polymers.
    Koch N; Jennotte O; Gasparrini Y; Vandenbroucke F; Lechanteur A; Evrard B
    Int J Pharm; 2020 Nov; 589():119812. PubMed ID: 32882367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precipitation complexation method produces cannabidiol/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol.
    Mannila J; Järvinen T; Järvinen K; Jarho P
    J Pharm Sci; 2007 Feb; 96(2):312-9. PubMed ID: 17051591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug.
    Bao Z; Yung F; Hickman RJ; Aspuru-Guzik A; Bannigan P; Allen C
    Drug Deliv Transl Res; 2024 Jul; 14(7):1872-1887. PubMed ID: 38158474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology.
    Atsmon J; Heffetz D; Deutsch L; Deutsch F; Sacks H
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):751-758. PubMed ID: 29125702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
    Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
    J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.
    Stott CG; White L; Wright S; Wilbraham D; Guy GW
    Eur J Clin Pharmacol; 2013 Apr; 69(4):825-34. PubMed ID: 23052407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo.
    Chu PC; Liao MH; Liu MG; Li CZ; Lai PS
    Int J Nanomedicine; 2024; 19():4321-4337. PubMed ID: 38770103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid.
    Majimbi M; Brook E; Galettis P; Eden E; Al-Salami H; Mooranian A; Al-Sallami H; Lam V; Mamo JCL; Takechi R
    PLoS One; 2021; 16(6):e0243858. PubMed ID: 34138862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial.
    De Prá MAA; Vardanega R; Loss CG
    Int J Pharm; 2021 Nov; 609():121159. PubMed ID: 34624443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-Based Analysis of Cannabidiol Dose-Exposure Relationship and Bioavailability.
    Lim SY; Sharan S; Woo S
    Pharmacotherapy; 2020 Apr; 40(4):291-300. PubMed ID: 32058609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.
    Kok LY; Bannigan P; Sanaee F; Evans JC; Dunne M; Regenold M; Ahmed L; Dubins D; Allen C
    Eur J Pharm Sci; 2022 Jan; 168():106058. PubMed ID: 34763088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.